Skip to main content

CASE REPORT article

Front. Cardiovasc. Med., 26 April 2024
Sec. Cardiovascular Surgery

Case Report: Giant cholesterol granuloma in the anterior mediastinum

\r\nMilica LudoskiMilica Ludoski1Igor Zivkovic,
Igor Zivkovic1,2*Petar Milacic,Petar Milacic1,2Novica Boricic,Novica Boricic2,3Slobodan Micovic,Slobodan Micovic1,2Milovan BojicMilovan Bojic1Zoran Tabakovic\r\nZoran Tabakovic1
  • 1Cardiac Surgery Department, Dedinje Cardiovascular Institute, Belgrade, Serbia
  • 2Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • 3Institute of Pathology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Cholesterol granuloma is a rare entity, which can develop in many regions of the body, accounting at most 1% of all mediastinal tumors. Etiology of this granuloma is still not clearly understood. The gold standard choice of treatment for cholesterol granuloma is total surgical resection. Symptomatic mediastinum granuloma can be easily diagnosed, but if mass effect is not evident then diagnosis of this tumor is really challenging. We present a rare case of huge cholesterol granuloma in the anterior mediastinum of the patient who underwent on elective coronary artery graft bypass surgery.

Background

Cholesterol granuloma is a rather uncommon entity. It is a benign tumor that can form in many different parts of the body, accounting for 1% of all mediastinal tumors (1). It is a reactive lesion caused by cholesterol crystals and foreign body giant cells (2). Because of its rarity, preoperative identification of mediastinal cholesterol granuloma might be difficult, however it is usually discovered incidentally during cardiac surgical operations (1). We describe an unusually large cholesterol granuloma in the patient's anterior mediastinum after elective heart surgery.

Case description

A 46-year-old man was referred to our institution for an coronary artery bypass graft surgery. He had angina symptoms such as shortness of breath and chest discomfort. Previously, there have been hypertension, dyslipidemia, and spontaneous pneumothorax. There was no prior history of chest trauma. The physical exam, laboratory results, and chest radiography were all unremarkable. We discovered a tumorous mass in the anterior mediastinum after a medial sternotomy. It was found in the mediastinal fat tissue in the projection of the thymus adherent on the pericardium. There were no complaints of a mass impact or structural deterioration in the mediastinum. A 11 × 4 cm multinodular tumor encapsulated in brown and yellow hue on the surface (Figures 1A,B). The tumor was completely surgically removed, followed by elective coronary artery bypass graft surgery. The patient's postoperative course was unremarkable. A histopathological investigation revealed a large number of cholesterol crystals enclosed by hyalinized collagen fibers. At increased magnification, macrophages, foreign-body type large cells, and dystrophic calcification were seen. There was no indication of cytologic atypia, mitotic activity, or necrosis, excluding the possibility of malignancy (Figures 2A,B).

Figure 1
www.frontiersin.org

Figure 1. Surgical view on the tumorous mass. (A) Tumor into the mediastinum, view through the median sternotomy. (B) Completely extirpated tumor.

Figure 2
www.frontiersin.org

Figure 2. Hematoxylin—eosin staining of tumor tissue. (A) H&E magnification 4×. (B) H&E magnification 10×.

Discussion

Cholesterol granuloma in the anterior mediastinum in the thymus projection is an uncommon occurrence (1). It develops as a result of a foreign-body giant cell reactivity to cholesterol crystals. Cholesterol granuloma is histologically composed of granulation tissue with masses of cholesterol crystals surrounded by giant cells, macrophages, and lymphocytes. This aspect is significant since it is something that must be mentioned on a pathohistological test to identify cholesterol granuloma (2). The origin and pathophysiology of this granuloma are currently unknown. It might manifest as a result of chronic inflammation or as a result of trauma or a chest injury (2, 3). Chronic inflammation causes cell damage and hemolysis. Hemolysis liberates cholesterols from deteriorated cell membranes, allowing them to crystallize. Cholesterol crystals activate macrophages and foreign-body type giant cells, causing these cells to aggregate and cause persistent inflammation and granuloma development (4). Systemic variables such as dyslipidemia and hypertension are risk factors for the development of cholesterol granuloma because they can disrupt microcirculation, resulting in microhemorrhage and cell degeneration (1). Microhaemorrhage and cell degeneration also maintain chronic inflammation in the fat tissue what lead to granuloma formation. Granuloma formation is some kind of a tissue response. All of these systemic issues are affecting our patient. Cholesterol granuloma can form in any area of the body where there is cholesterol crystal deposition. However, granuloma is most commonly found at the petrous apex of the temporal bone and the middle ear, where it is associated with persistent inflammation. Aside from that, only a few instances have been described in the anterior mediastinum (2, 4). Cholesterol granuloma development in the anterior mediastinum has been observed as a multilocular thymic cyst against a background of chronic inflammation of the thymic parenchyma and in the case of thymic seminoma. However, just one example of this kind of granuloma development in the upper mediastinum has been recorded (3). Symptoms and clinical presentation vary and may be owing to space occupying effects on adjacent tissues, or the granuloma may be asymptomatic and only be detected accidentally. The diagnosis, management, and therapy of cholesterol granuloma are mostly guided by the location, size, and appearance of the tumor. Preoperative diagnosis of cholesterol granuloma in the mediastinum might be difficult and challenging. It can be found incidentally on imaging done for some different reasons and it is important to have this as a potential differential diagnosis. The following imaging techniques are used for diagnosis: computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and chest radiography (posterior-anterior and lateral projection). CT scan shows well-circumscribed tumour mass. MRI often shows a low signal intensity on T1- and T2-weighted images due to numerous collagen fibers in granuloma. On positron emission tomography (PET) granuloma is positive. PET scan shows high fluoro-2-deoxy-D-glucose uptake in tumour like other malignant mediastinal tumours. It would be easier to evaluate and potentially diagnose this kind of tumour with preoperative imaging with CT or MRI, but in our case, our patient did not have any unusual symptoms in spite of angina symptoms. Because of that and because of patient's age, we did not perform any of this, neither CT, nor MRI. CT or MRI are not routinely performed in patients with coronary disease who underwent only coronary artery bypass grafting surgery. Hongo et al. describe a case of cholesterol granuloma in the antherior mediastinum. Their patient was man with an incidental finding of anterior mediastinal mass by PET scan. (5) Their patient was asymptomatic, without comorbidities, but he was rugby player with often chest trauma in history. In their case often patient's trauma was important and one of the main factors that lead to formation of this granuloma in mediastinum. Although there are a few diagnostic procedures available, due to its rarity and radiological appearances that resemble more frequent mediastinal tumors, an exact and correct diagnosis cannot be achieved without a pathohistological exam (1). Cholesterol granuloma is a space-occupying lesion that is benign, with no erosion of tissues in the mediastinum, and it can be discovered as an accidental discovery during cardiac surgery (4). The procedure of choice is total surgical resection. Weissferdt et al. investigated four individuals who had mediastinal cholesterol granuloma. Three years following full surgical excision of their lesions, they were followed up on. Clinical follow-up on the four patients has revealed no indication of recurrence, and all are alive and well (6).

Conclusion

Asymptomatic cases of cholesterol granuloma are more difficult to diagnose than symptomatic cases, unless they are accidentally discovered during a preoperative CT or MRI chest screening. Most cases of cholesterol granuloma in the anterior mediastinum, or in the whole mediastinum, are asymptomatic, making it a rather uncommon disorder. Consequently cardiac or chest surgery often revealed all of those cholesterol granulomas. The most effective strategy for treatment is a complete surgical resection; after extirpation, there is no evidence that the condition will recur.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Ethics statement

Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.

Author contributions

ML: Visualization, Writing – original draft. IZ: Conceptualization, Visualization, Writing – original draft. PM: Conceptualization, Supervision, Writing – original draft. NB: Visualization, Writing – original draft. SM: Supervision, Writing – original draft. MB: Formal analysis, Supervision, Validation, Writing – review & editing. ZT: Investigation, Writing – original draft.

Funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Manabe T, Oka S, Ono K. Multifocal cholesterol granulomas of the anterior mediastinum. Surg Case Rep. (2020) 6(1):182. doi: 10.1186/s40792-020-00943-5

PubMed Abstract | Crossref Full Text | Google Scholar

2. Krishnan TR, Sinha SK, Kejriwal NK. A rare case of cholesterol granuloma in the anterior mediastinum. Heart Lung Circ. (2013) 22(4):303–4. doi: 10.1016/j.hlc.2012.07.009

PubMed Abstract | Crossref Full Text | Google Scholar

3. Fujimoto K, Takamori S, Yano H, Sadohara J, Matsuo T, Terazaki Y, et al. Focal cholesterol granuloma in the anterior mediastinum: [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and magnetic resonance imaging findings. J Thorac Oncol. (2007) 2(11):1054–6. doi: 10.1097/JTO.0b013e318158eee8

PubMed Abstract | Crossref Full Text | Google Scholar

4. Drury NE, Smith DN, Phillips LM, Trotter SE, Kalkat MS. Cholesterol granuloma of the anterior mediastinum. Thorax. (2017 Jul) 72(7):671–2. doi: 10.1136/thoraxjnl-2016-209481

PubMed Abstract | Crossref Full Text | Google Scholar

5. Hongo T, Jiromaru R, Kuga R, Matsuo M, Oda Y, Nakagawa T. Cholesterol granuloma of the anterior mediastinum: a case report and literature review. Int J Surg Case Rep. (2023) 111:108852. doi: 10.1016/j.ijscr.2023.108852

PubMed Abstract | Crossref Full Text | Google Scholar

6. Weissferdt A, Kalhor N, Moran C. Primary thymic cholesteroloma: a clinicopathological correlation of four cases of an unusual benign lesion. Virchows Arch. (2015) 467(5):609–11. doi: 10.1007/s00428-015-1822-8

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: cholesterol granuloma, mediastinum, open heart surgery, CABG, tumor

Citation: Ludoski M, Zivkovic I, Milacic P, Boricic N, Micovic S, Bojic M and Tabakovic Z (2024) Case Report: Giant cholesterol granuloma in the anterior mediastinum. Front. Cardiovasc. Med. 11:1359731. doi: 10.3389/fcvm.2024.1359731

Received: 21 December 2023; Accepted: 4 March 2024;
Published: 26 April 2024.

Edited by:

Robert Jeenchen Chen, Stanford University, United States

Reviewed by:

Alexandra White, University Hospital Galway, Ireland
Kanhua Yin, University of Missouri–Kansas City, United States

© 2024 Ludoski, Zivkovic, Milacic, Boricic, Micovic, Bojic and Tabakovic. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Igor Zivkovic aWdvcjg4eml2a292aWNAZ21haWwuY29t

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.